Amino-terminally truncated RANTES as chemokine antagonists

Details Amino-terminally truncated RANTES as chemokine antagonists Amino-terminally truncated RANTES as chemokine antagonists

2005-12-20

2005-12-20

Mertz, Prema (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

C530S324000, C514S002600, C514S008100, C514S012200, C514S885000

Reexamination Certificate

active

06977071

ABSTRACT:
The present invention relates to amino-terminally truncated RANTES, lacking NH2-terminal amino acids corresponding to amino acid residues 1, 1-2, 1-3 or 1-4 of the naturally-occurring RANTES and having chemokine antagonistic activity, as well as cDNA sequences encoding them, their use in therapy and/or in diagnosis of the diseases, in which an antagonistic activity of the chemokine effects is required, and pharmaceutical compositions comprising them.

REFERENCES:
patent: 5739103 (1998-04-01), Rollins et al.
patent: 6168784 (2001-01-01), Offord et al.
patent: WO 96/17935 (1996-06-01), None
Noso et al J. Immunol. 1996; 156: 1946-1953.
Sozzani et al.,Journal of Immunology, 152:3615-3622 (1994).
Proudfoot et al.,Journal of Biological Chemistry, 271(5):2599-2603 (1996).
Proost et al.,Biochemistry, 32 10170-10177 (1993).
Proost et al.,Journal of Immunology., 150:1000-1010, No. 3 (1993).
Proost et al.,METHODS: A Companion to Methods in Enzymology, 10:82-92 (1996).
Proost et al.,Cytokine, 7(2):97-104 (1995).
Grynkiewicz et al.,Journal of Biological Chemistry, 260(6):3440-3450 (1985).
De Meester et al.,Journal of Immunological Methods, 189:99-105 (1996).
Clark-Lewis et al.,Journal of Biological Chemistry266(34:23128-23134 (1991).
Baggiolini et al.,Ann. Rev. Immunol., 15:675-705 (1997).
Baggiolini et al.,Advances in Immunology, 55:97-179 (1994).
Van Damme, et al.,J. Exp. Med., 176:59-65 (1992).
Arenzana-Selsdedis et al.,Nature, 383: 400 (1996).
Gong et al.,Journal of Biological Chemistry, 271(18) 10521-10527 (1996).
Gong et al.,J. Exp. Med., 181:631-640 (1995).
Van Damme et al.,Eur. J. Immunol., 20:2113-2118 (1990).
Van Damme et al.,Eur. J. Biochem., 181,:337-344 (1989).
Van Coillie et al.,Biochemical and Biophysical Research Communications, 231:726-730 (1997).
Oravecz et al.,Journal of Experimental Medicine, 186(11): 1865-1872 (1997).
Schall et al.,Journal of Immunology, 41(3):1018-1025 (1998).
Schols et al.,J. Exp. Med., 186(8):1383-1388 (1997).
Deng et al.,Nature, 381:661-666 (1996).
Wuyts et al.,Biochemistry, 36:2716-2723 (1997).
Taub.,Cytokine&Growth Factor Reviews, 7(4):355-376 (1996).
Watz et al.,Biochemical and Biophysical Research Communications, 159(3):969-975 (1989).

Affiliated with

Also associated with

Rating

Amino-terminally truncated RANTES as chemokine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amino-terminally truncated RANTES as chemokine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-terminally truncated RANTES as chemokine antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3482010